1,200 articles
Robert A. Figlin
Robert A. Figlin is an American medical oncologist specializing in kidney and thoracic cancers who led the 2007 phase 3 trial establishing sunitinib as first-line therapy for metastatic kidney cancer.
Robert A. Weinberg
Robert A. Weinberg is an American cancer biologist at MIT and the Whitehead Institute who discovered the first human oncogene, Ras, and wrote "The Hallmarks of Cancer" (2000).
Robert C. Bast
Robert C. Bast is an American oncologist best known for identifying the CA 125 biomarker for ovarian cancer, and a longtime translational research leader at MD Anderson in Houston.
Robert C. Doebele
Robert C. Doebele is an American thoracic oncologist who identified oncogenic NTRK1 fusions in lung cancer, led entrectinib trials, and co-founded Rain Therapeutics before joining Boundless Bio in 2025.
Robert C. Seeger
Robert C. Seeger was an American pediatric oncology researcher at Children's Hospital Los Angeles who established the prognostic importance of MYCN amplification in neuroblastoma and founded the NANT consortium.
Robert D. Schreiber
Robert D. Schreiber is an American tumor immunologist and Bursky Distinguished Professor at Washington University School of Medicine in St. Louis, known for originating the cancer immunoediting concept.
Robert Daniel Beauchamp
R. Daniel Beauchamp (1956–2022) was an American surgical oncologist and cancer biologist at Vanderbilt University Medical Center, known for research on colorectal cancer invasion, metastasis, and biomarker discovery.
Robert E. Coleman
Robert E. Coleman is a British medical oncologist and Emeritus Professor of Medical Oncology at the University of Sheffield, known for research on bone metastases in breast cancer.
Robert F. Ozols
Robert F. Ozols is an American medical oncologist specializing in ovarian cancer, known for research on tumor drug resistance and for chemotherapy regimens that became standard first-line treatment.
Robert H. Vonderheide
Robert H. Vonderheide is an American oncologist and cancer immunologist who directs the Abramson Cancer Center at Penn, known for CD40 immunotherapy and pancreatic cancer research.
Robert I. Haddad
Robert I. Haddad, also published as Robert Haddad, is a medical oncologist specializing in head and neck cancer who leads Dana-Farber's head and neck oncology division.
Robert J. Coffey
Robert J. Coffey is an American physician-scientist at Vanderbilt University Medical Center, the Ingram Professor of Cancer Research, known for work on EGFR signaling and colorectal cancer.
Robert J. Motzer
Robert J. Motzer, also known as R.J. Motzer, is a medical oncologist at Memorial Sloan Kettering Cancer Center who created the MSKCC kidney cancer prognostic model and led pivotal kidney cancer drug trials.
Robert J. Schneider
Robert J. Schneider is an American cancer researcher and Albert B. Sabin Professor at NYU Grossman School of Medicine who studies breast cancer translation control.
Robert L. Martuza M.D.
Robert L. Martuza is a neurosurgeon and neuroscientist at Massachusetts General Hospital and Harvard Medical School, known as a founder of oncolytic herpes virotherapy for brain tumors.
Robert N. Hoover
Robert N. Hoover is an American cancer epidemiologist who spent 48 years at the National Cancer Institute, leading the DES Follow-up Study of prenatal drug exposure.
Robert Noble (Canadian physician)
Robert Noble (1910–1990) was a Canadian physician who, with chemist Charles Beer, discovered the anticancer drug vinblastine in the Madagascar periwinkle, a plant originally studied as a folk diabetes remedy.
Robert S. DiPaola
Robert S. DiPaola is an American medical oncologist known for leading prostate cancer trials including CHAARTED, and provost of the University of Kentucky since 2022.
Robert W. Miller
Robert W. Miller (1921–2006) was an American pediatrician and cancer epidemiologist who spent over 35 years at the National Cancer Institute and studied atomic-bomb radiation effects on children in Hiroshima.
Robert Z. Orlowski
Robert Z. Orlowski is a physician-scientist at MD Anderson Cancer Center who led the first clinical studies of bortezomib and the IMROZ trial of isatuximab for multiple myeloma.
Robert Zeiser
Robert Zeiser (born 1975) is a German hematology and oncology physician-scientist at the University of Freiburg known for developing ruxolitinib therapy for steroid-refractory graft-versus-host disease.
Roberto Chiarle
Roberto Chiarle is an Italian molecular pathologist, Professor of Pathology at Harvard Medical School since 2020, known for ALK cancer vaccines, translocation sequencing, and founding ALKemist Bio.
Robin A. Weiss
Robin A. Weiss, also known as Robin Weiss, was a British virologist and Emeritus Professor of Viral Oncology at University College London, known for discovering endogenous retroviruses and identifying CD4 as the HIV receptor.
Robyn L. Ward
Robyn L. Ward is an Australian oncology researcher who showed some hereditary colorectal cancer is caused by inherited MLH1 epimutations, and later served as a senior university research leader.
Roel Verhaak
Roel Verhaak, born 1976, is a Dutch cancer genomics researcher and Professor of Neurosurgery at Yale known for defining the gene expression subtypes of glioblastoma, called the Verhaak subtypes.
Roger Stupp
Roger Stupp is a Swiss neuro-oncologist and Chief of Neuro-oncology at Northwestern University, known for the Stupp protocol, the global standard glioblastoma treatment since 2005.
Rogier Versteeg
Rogier Versteeg (born 1955) is a Dutch cancer biologist who has led the Department of Oncogenomics at Amsterdam UMC since 2003, known for neuroblastoma research.
Roland M. Schmid
Roland M. Schmid is a German internist and pancreatic cancer researcher, professor and director of the II. Medical Clinic at the Technical University of Munich since 2002.
Roland Rad
Roland Rad is a physician-scientist, professor of Molecular Oncology and Functional Genomics at the Technical University of Munich, known for genetic screening studies of cancer evolution, metastasis, and drug resistance.
Roman K. Thomas
Roman K. Thomas, also known as Roman Thomas, is a German physician-scientist in translational genomics who studies lung cancer genome evolution, especially small cell lung cancer.